Evolus (EOLS) Cash from Financing Activities (2017 - 2026)

Evolus (EOLS) posted Cash from Financing Activities of $7.6 million for Q1 2026, up 9794.81% on a QoQ basis from $77000.0 in Q4 2025, and up 567.14% year-over-year from $1.1 million in Q1 2025.

Evolus (EOLS) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Evolus' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $7.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 567.14% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.6 million (up 21872.73% YoY) and the FY2025 annual result came in at $17.3 million, down 63.43% from the prior year.
  • Cash from Financing Activities was $7.6 million for Q1 2026 at Evolus, up from $77000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $45.7 million in Q1 2024 and bottomed at -$1.8 million in Q3 2025.
  • A 5-year average of $6.6 million and a median of -$849000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 109.3% — and 2024, when it surged 3661.78%.
  • Evolus' Cash from Financing Activities stood at -$1.5 million in 2022, then jumped by 1651.58% to $23.5 million in 2023, then tumbled by 105.58% to -$1.3 million in 2024, then jumped by 105.86% to $77000.0 in 2025, then surged by 9794.81% to $7.6 million in 2026.
  • Business Quant data shows EOLS's Cash from Financing Activities at $7.6 million in Q1 2026, $77000.0 in Q4 2025, and -$1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn 7.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.62 Mn
Mar 31, 2026 7.62 Mn
Dec 31, 2025 77,000.00
Dec 31, 2025 77,000.00
Sep 30, 2025 -1.77 Mn
Sep 30, 2025 -1.77 Mn
Jun 30, 2025 20.66 Mn
Jun 30, 2025 20.66 Mn
Mar 31, 2025 -1.63 Mn
Mar 31, 2025 -1.63 Mn
Dec 31, 2024 -1.31 Mn
Dec 31, 2024 -1.31 Mn
Sep 30, 2024 -1.42 Mn
Sep 30, 2024 -1.42 Mn
Jun 30, 2024 4.48 Mn
Jun 30, 2024 4.48 Mn
Mar 31, 2024 45.66 Mn
Mar 31, 2024 45.66 Mn
Dec 31, 2023 23.52 Mn
Dec 31, 2023 23.52 Mn